PatientsVille.com Logo

NAUSEA and Ambien

PatientsVille

NAUSEA Symptoms and Causes

Nausea is an uneasy or unsettled feeling in the stomach together with an urge to vomit. Nausea and vomiting, or throwing up, are not diseases. They can be symptoms of many different conditions. These include morning sickness during pregnancy, infections, migraine headaches, motion sickness, food poisoning, cancer chemotherapy or other medicines.

For vomiting in children and adults, avoid solid foods until vomiting has stopped for at least six hours. Then work back to a normal diet. Drink small amounts of clear liquids to avoid dehydration.

Nausea and vomiting are common. Usually, they are not serious. You should see a doctor immediately if you suspect poisoning or if you have

  • Vomited for longer than 24 hours
  • Blood in the vomit
  • Severe abdominal pain
  • Headache and stiff neck
  • Signs of dehydration, such as dry mouth, infrequent urination or dark urine

Check out the latest treatments for NAUSEA

NAUSEA treatment research studies

Ambien clinical trials, surveys and public health registries


Find Drug Side Effect reports



Ambien Side Effects

Amnesia (650)
Somnambulism (372)
Road Traffic Accident (273)
Fall (233)
Abnormal Behaviour (217)
Impaired Driving Ability (191)
Abnormal Sleep-related Event (189)
Confusional State (153)
Hallucination (147)
Anxiety (127)
Depression (123)
Loss Of Consciousness (113)
Dizziness (106)
Sleep Walking (102)
Insomnia (101)
Pain (97)
Headache (92)
Feeling Abnormal (91)
Somnolence (89)
Contusion (85)
Memory Impairment (85)
Fatigue (83)
Nausea (82)
Aggression (80)
Back Pain (73)
Asthenia (67)
Eating Disorder (67)
Suicidal Ideation (66)
Hallucination, Visual (64)
Disorientation (63)
Chest Pain (61)
Dyspnoea (60)
Diarrhoea (54)
Vomiting (52)
Arthralgia (52)
Completed Suicide (51)
Overdose (51)
Balance Disorder (51)
Agitation (50)
Sleep-related Eating Disorder (46)
Nightmare (45)
Malaise (43)
Gait Disturbance (43)
Sleep Talking (42)
Head Injury (40)
Intentional Overdose (38)
Weight Increased (38)
Injury (36)
Incorrect Dose Administered (35)
Convulsion (35)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

syptoms nausea, sweating dilated pupils unable to sleep, fever, tight chest,high white blood cells, high levels of creatine phosphokinase and myoglobin. what the hell is worng with me?

Ambien helped me get through all those sleepless nights. I'm happy with this product that I got at www.medsheaven.com

Christmas morning when i first woke i didnt feel like myusual selfi felt tired or i had low energy,later during the day i ate then soon after i had eaten i started feeling nautious for hours until finally when i went to

Have you tried Agrisept-L?

Have you tried Bactine spray and Triple Antibiotic Ointment and Robaxin and Nystatin and Fluconazole?

Have you tried Cogentin?

Have you tried physical therapy?

Hi iam 20 years old & this is my third day feeling sick second two be vomiting everything ..today I poop black. What can I have

I am 7 years post-op for gastric bypass. I suddenly started frequent nausea. Then sttarted waking up from a sound sleep nauseated and dry heaving. I dry heave so much at time I have stomach spasms. What could this be a sign of? Is my surgery messed u

I am a 49 year old female who was presecribed Ambien 10mg for insomnia. I took the medication for two years. I developed parathesias throughout my body, mostly in my face; extreme muscle pain to the point of rigidity. My symptoms

As mentioned in many reviews i have read I experienced the first 2 months with lots of purging white heads etc. Now my skin is clear and smooth with scars clearing rapidly. Over the last 3 weeks i am experiencing nausea and headaches mild to heav

I have been on Abiraterone for 1 week now and have experienced tiredness, headaches, and nausea Are the common systems?

I have ulcerative colitis, I have had 9 treatments of Remicade and have decided to stop. I have a lympnode in my neck that is enlarged now, I am so so tierd all the time, I have nausea all the time and now get more allergic reactions to things. M

Side effects I have from Nadolol are confusion, dizziness, lightheaded, increased depression and anxiety, and mild nausea.

dehydration, nausea, vommiting, confustion, trouble regulating body tempurature, profuse sweating, headaches, etc, etc, etc. I stopped after 8 days. felt like I was dying. I HATE this stuff!!!!

I took midol for the first time today. Im feeling shaky, but no nausea. I feel like i have to burp, and i constantly feel like i have to go to the bathroom. Its helping the pain, but not making go away. Atleast i can stand. I was feeling si

syptoms nausea, sweating dilated pupils unable to sleep, fever, tight chest,high white blood cells, high levels of creatine phosphokinase and myoglobin. what the hell is worng with me?

<b>Describe Your Ezetrol Experience Here:</b>Sleeplessness severe pain in muscles and joints nausea and abdominal pain headaches and pain behind eyes chronic fatigue and flat mood

I ASKED MY GP FOR CHAMPIX AS I HAD SUDDENLY DECIDED AFTER SMOKING FOR 22YEARS. I TRIED PATCHES IN THE PAST ADN COLD TURKEY. PATCHES CAUSED CHEST PAIN, BLOOTING, CONSTIPATION,NAUSEA,SWEATS,

Just started with Sifrol 0,18 one per day...and first side effect was ...nose bliding and nausea... diagnose ...RSL

NAUSEA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery
Conditions: Post-operative Nausea;   Post-operative Vomiting;   Post-discharge Nausea;   Post-discharge Vomiting
Intervention: Other: Anesthesia and postoperative medication and fluid protocol
Outcome Measures: Post-operative nausea and vomiting;   Hospital length of stay;   Post-discharge nausea and vomiting
2 Recruiting Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
Conditions: Chemotherapy-induced Nausea and Vomiting;   Moderate Emetogenic Chemotherapy
Intervention:
Outcome Measures: To evaluate the role of some predictive biomarkers for chemotherapy-induced nausea and vomiting;   To evaluate the clinical characteristics related to chemotherapy-induced nausea and vomiting in Korean patients
3 Not yet recruiting Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer;   Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Olanzapine;   Drug: Chemotherapy (cisplatin or cyclophosphamide and doxorubicin);   Drug: Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant);   Other: Placebo
Outcome Measures: Proportion of patients with no nausea, defined as a response of 0 in the nausea item of Nausea and Vomiting Daily Diary/Questionnaire;   Nausea scores measured by the Nausea and Vomiting Daily Diary/Questionnaire;   Complete response, defined as no emetic episodes and no use of rescue medication measured by the Nausea and Vomiting Daily Diary/Questionnaire;   Incidence of potential toxicities related to olanzapine as measured by the Nausea and Vomiting Daily Diary/Questionnaire;   Frequency of rescue medication repeatedly measured by the Nausea and Vomiting Daily Diary/Questionnaire
4 Not yet recruiting Inhalation Intervention for Nausea in the Emergency Department
Conditions: Nausea;   Vomiting
Interventions: Other: Alcohol prep pad group;   Other: Placebo Normal Saline prep pad
Outcome Measures: Significant change in level of nausea.;   Time to effect for significant change in nausea level
5 Recruiting Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Conditions: Breast Cancer;   Nausea;   Vomiting
Interventions: Drug: granisetron transdermal system;   Drug: fosaprepitant dimeglumine;   Other: laboratory biomarker analysis
Outcome Measures: Proportion of patients with complete response, defined as no emesis and no use of rescue medication in acute phase (within first 24 hours of treatment);   Proportion of patients with complete response, defined as no emesis and no use of rescue medication in delayed phase (within 2-4 days of treatment);   Proportion of patients with complete response, defined as no nausea, defined as Visual Analog Scale (VAS) less than 5 mm on a 0-100mm horizontal scale in acute phase (within 24 hours of treatment);   Proportion of patients with complete response, defined as no nausea, defined as VAS less than 5 mm on a 0-100mm horizontal scale in delayed phase (within 2-4 days of treatment);   Proportion of patients with partial response, defined as 2 or fewer episodes of emesis (Common Terminology Criteria for Adverse Events [CTCAE] version 4.0 grade 1-2), regardless of the use of rescue antiemetic medications (in acute and delayed phase);   Proportion of patients with treatment failures, defined as more than 2 episodes of emesis (CTCAE version 4.0 grade 2 or greater), regardless of the use of rescue antiemetic medications;   Proportion of patients with partial response, defined as no significant nausea, defined as VAS less than 25 mm on a 0-100mm horizontal scale (in acute and delayed phase);   Proportion of patients who developed nausea and vomiting in the first course of treatment out of all enrolled patients;   Proportion of patients who developed grade 1, 2, 3, or 4 nausea and vomiting with all courses of treatment out of all patients who developed nausea and vomiting;   Proportion of patients who developed nausea and vomiting on all courses;   Proportion of patients who experience grade 1, 2, 3, or 4 adverse events out of all patients who have received study drugs;   Proportion of patients who missed 0, 1, or more than 2 doses of scheduled antiemetic medication at home on days 2 to 3, out of all patients
6 Recruiting Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexamethasone;   Drug: Placebo
Outcome Measures: Incidence of post-operative nausea and/or vomiting;   Total consumption of anti-emetic medications;   Subject's self-reported visual analog scale (VAS) pain scores;   Overall satisfaction
7 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
Outcome Measures: Complete Response rate (no vomiting and no rescue anti-emetic therapy);   Complete Response rate;   Proportion of patients who did not vomit;   No Significant Nausea: The proportion of patients who did not experience any nausea ≥ 3 on 0 - 10 scale;   No Nausea: The proportion of patients who did not experience any nausea. Nausea = 0 on 0 - 10 scale;   Complete Protection: The proportion of patients who did not vomit, require rescue therapy, or have nausea ≥ 3 on 0 - 10 scale;   Total Protection: The proportion of patients who did not vomit, require rescue therapy, or have any nausea (Nausea = 0 on 0 - 10 scale).;   Vomiting frequency: The frequency of vomiting (# episodes per week) in patients who did vomit at least once.;   Nausea frequency: The frequency of nausea (Nausea > 0 in a given week/ number of weeks during overall period of radiation treatment);   Significant Nausea frequency: The frequency of significant nausea (Nausea ≥ 3 in a given week/ number of weeks during overall period of radiation treatment);   Frequency of rescue medication use: The number of days in which rescue medication was taken / number of days of radiotherapy;   Time to Failure: The time period in days from the start of radiation until the first vomiting episode or use of rescue medication for all patients and for the subset of patients who do not have a Complete Response.;   All adverse events that occur during radiation treatment with assessment of severity (CTC v.3) and relationship to study drug.
8 Unknown  B6 Treatment for Nausea and Vomiting in Pregnancy
Condition: Nausea and Vomiting Complain in Early Pregnancy
Intervention: Drug: vitamin B6
Outcome Measures: Nausea and vomiting score;   Vitamin B6 concentration in nausea and vomiting of pregnancy
9 Not yet recruiting Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Intervention: Device: pharyngeal pack
Outcome Measures: the incidence and severity of any nausea, emetic episodes (retching or vomiting), or both (i.e., postoperative nausea and vomiting) during the first 24 postoperative hours.;   The incidence and severity of throat pain;   the incidence of oral mucosal injury;   satisfactory scores of patients
10 Recruiting Efficacy Study of Ginger (Zingiber Officinale) Extract to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy
Conditions: Cancer;   Nausea;   Vomiting
Intervention: Dietary Supplement: Standardized Ginger extract
Outcome Measures: To evaluate the efficacy of Ginger in protecting patients from delayed nausea (incidence of no delayed nausea and non-significant delayed nausea);   Protection from delayed vomiting (number of emetic episodes in delayed phase);   Use of antiemetic rescue medication.;   Overall fatigue assessment (BFI questionnaire)
11 Recruiting Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy
Condition: Acute Leukemia
Intervention:
Outcome Measures: Acute Chemotherapy-Induced Nausea and Vomiting;   Anticipatory Chemotherapy-Induced Nausea and Vomiting;   Delayed Chemotherapy-Induced Nausea and Vomiting
12 Recruiting Alternative Approaches for Nausea Control
Condition: Nausea
Interventions: Device: Acupressure bands;   Other: Version 1 handout;   Behavioral: Version 1 MP3;   Other: Version 2 handout;   Behavioral: Version 2 MP3
Outcome Measure: patient report nausea diary
13 Unknown  Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
Outcome Measures: the incidences of nausea, vomiting, need for rescue medication;   incidences of unplanned hospital admission; duration of PACU stay
14 Unknown  Does Thiamine Help Vomiting and Nausea in Pregnancy?
Condition: Hyperemesis Gravidarum
Intervention: Drug: thiamine & promethazine
Outcome Measure: the improvement in nausea and/or vomiting after treatment
15 Recruiting Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
Condition: Chemotherapy Induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Aprepitant
Outcome Measures: Feasibility of recruitment and data collection.;   Complete Response in Overall Phase;   Complete Response in Acute Phase;   Complete Response in Delayed Phase;   Good control of nausea
16 Recruiting Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
Conditions: Nausea;   Vomiting
Interventions: Device: Acupressure Wrist Bands (Sea-Bands);   Device: Placebo wristbands
Outcome Measures: Number of PRN Doses of anti-emetics needed;   Visual Analogue Scale of nausea; duration of perceived nausea; number of vomits per 24 hours; volume of vomit per 24 hours; adverse effects of acupressure; measure of whether the patient felt the intervention helped.
17 Recruiting Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
Condition: Emesis
Interventions: Drug: Dexamethasone, Ondansetron, Aprepitant;   Other: Arm A: Standard Anti-emetic regimen
Outcome Measures: Incidence of change in acute emesis (nausea and/or vomiting) in both study arms;   Incidence of change in the delayed emesis (nausea and/or vomiting) in both study arms
18 Recruiting A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225 AM1) (KMEC)
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Aprepitant Placebo;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).
Outcome Measures: The Proportion of Participants with Overall No Vomiting for the Overall Stage;   Number of Participants with a Complete Response - Overall, Acute, and Delayed;   Time to First Vomiting Event Overall;   Number of Participants with No Vomiting and No Significant Nausea;   Number of Participants with No Impact on Daily Life - Overall;   Number of Participants with No Use of a Rescue Therapy - Overall, Acute, and Delayed;   Number of Participants with One or More Clinical Adverse Events;   No Vomiting - Acute and Delayed
19 Unknown  Postoperative Nausea/Vomiting and Acupressure
Condition: Postoperative Nausea
Intervention: Procedure: Acupressure wrist band
Outcome Measures: Effectiveness of acupressure for postoperative nausea in terms of less use of antiemetic drugs;   Reduction in use of antiemetic medication as a consequence of the introduction of acupressure wristband
20 Recruiting Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Condition: Gastroparesis
Interventions: Drug: Aprepitant;   Drug: Placebo
Outcome Measures: Primary Outcome Measure;   Gastrointestinal symptoms;   Physiology